SCHEMBL1243983

SCHEMBL1243983

O=C1NC(=S)S/C1=C/c1cc(CCc2ccccc2)cs1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 5/20 0.55
▸ NAT1 P18440 2/20 0.55
▸ CA2 P00918 1/20 0.55
▸ EPHX1 P07099 1/20 0.55
▸ ADAMTS5 Q9UNA0 3/20 0.53
▸ MMP13 P45452 2/20 0.51
▸ MMP3 P08254 1/20 0.51
▸ PIK3CG P48736 1/20 0.51
▸ PTP4A3 O75365 3/20 0.50
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ POLB P06746 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ RECQL P46063 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1243984 1.00 PIM1 (0.55) PIM1NAT1CA2EPHX1ADAMTS5
SCHEMBL1243980 1.00 PIM1 (0.55) PIM1NAT1CA2EPHX1ADAMTS5
SCHEMBL2224451 0.82 NAT1 (0.66) PIM1NAT1CA2EPHX1MMP13
SCHEMBL2224453 0.82 NAT1 (0.66) PIM1NAT1CA2EPHX1MMP13
SCHEMBL1244674 0.78 MYC (0.56) PIM1NAT1ADAMTS5PIK3CGPTP4A3
SCHEMBL1244675 0.78 MYC (0.56) PIM1NAT1ADAMTS5PIK3CGPTP4A3
SCHEMBL8176998 0.72 NAT1 (0.75) PIM1NAT1CA2EPHX1ADAMTS5
SCHEMBL8176997 0.72 NAT1 (0.75) PIM1NAT1CA2EPHX1ADAMTS5
SCHEMBL1812224 0.72 NAT1 (1.00) PIM1NAT1CA2EPHX1MMP13
SCHEMBL4416451 0.72 NAT1 (1.00) PIM1NAT1CA2EPHX1MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7884124-B2 such as 2-Fluoro-4H-furo[3,2-b]pyrrole-5-carboxylate acid, used for the treatment of neuropathic pain, Alzheimer's disease, schizophrenia, ataxia and convulsions SEPRACOR INC. (US) 2011-02-08 — — US disclosed
US-20080058395-A1 Fused heterocyclic inhibitors of D-amino acid oxidase SEPRACOR INC. (US) 2008-03-06 — — US disclosed
US-20080004327-A1 FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2008-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058395-A1 Fused heterocyclic inhibitors of D-amino acid oxidase DAO, DDO, AOX1 PIM1 4694/4885NAT1 481/4885CA2 988/4885
US-20080004327-A1 FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE DAO, DDO, AOX1 PIM1 4390/4885NAT1 694/4885CA2 208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback